06159978 is referenced by 182 patents and cites 22 patents.

This invention is directed to quinoline/quinoxaline compounds which inhibit platelet-derived growth factor tyrosine kinase and/or Lck tyrosine kinase, to pharmaceutical compositions comprising these compounds, and to the use of these compounds for treating a patient suffering from or subject to disorders/conditions involving cellular differentiation, proliferation, extracellular matrix production or mediator release and/or T cell activation and proliferation.

Title
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56.sup.lck tyrosine kinases
Application Number
864455
Publication Number
6159978
Application Date
November 24, 1998
Publication Date
December 12, 2000
Inventor
Martin P Maguire
Woburn
MA, US
Paul E Persons
Westborough
MA, US
Alfred P Spada
Lansdale
PA, US
Michael R Myers
Reading
PA, US
Agent
Peter Butch
Irving Newman
Assignee
Aventis Pharmaceuticals Product
NJ, US
IPC
C07D 241/36
A61K 31/498
View Original Source